@ approved treatments |
- 01: –¼‘OFCharlessansaa“Še“úF2020/09/02(…) 20:03
- financial burden brought on by cancer treatment. Biosimilars are intended to be lower cost, high-quality https://forum.zerogcommander.com/showthread.php?tid=10288 treatment options that have the potential to alleviate such burden. We sincerely hope our trastuzumab biosimilar will do exactly that,„r said Sang-Jin Pak, Senior Vice President and http://www.cydsblog.com/comment/reply/8 [source] [check]
Head of Commercial Division, Samsung Bioepis. „rAt Samsung Bioepis, we will continue to demonstrate our enduring commitment to biosimilars by further strengthening our pipeline and widening the availability of
- 02: –¼‘OForffpjomkq“Še“úF2020/10/16(‹à) 15:13
- ƒ`ƒLƒ`ƒLŒfŽ¦” Phase4—ƒAƒbhanIBBS
<a href="http://www.g51m0o4ws0iu02lo9c73vkv12u015wc2s.org/">aorffpjomkq</a>
[url=http://www.g51m0o4ws0iu02lo9c73vkv12u015wc2s.org/]uorffpjomkq[/url]
orffpjomkq http://www.g51m0o4ws0iu02lo9c73vkv12u015wc2s.org/ [source] [check]
-
-
|
|